All News
RheumNow Podcast – Back Talk Listener Questions (12.04.20)
Dr Jack Cush takes questions from RheumNow listeners
Read Article
#BestACR20Tweets
RT @RichardPAConway : Dr Kaellmark reports on immunogenicity of adjuvant herpes zoster subunit vaccine in RA patients treated with JAKi. 40 RA patients and 20 controls. Satisfactory serological responses and tolerability seen. @rheumnow #ACR20 Abstr#1997 https://t.co/TR9IS9hUgu
Dr. John Cush RheumNow ( View Tweet)
Missing the Mark: AxSpa Treat to Target (TICOSPA Trial): Dr. Lianne Gensler #ACR20
https://t.co/ePrhQ90kwD
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out our latest article from Richard Conway ( @RichardPAConway) #ACR20
The tantalising prospect of glucocorticoid-free treatments for systemic vasculitis
https://t.co/VG1ah3Nq5c https://t.co/js3l527VHg
Links:
Dr. John Cush RheumNow ( View Tweet)
Revisit #ACR20 through the RheumNow podcast. Day 2, Part III available now.
https://t.co/rgvlZzVMkX
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @MeralElRamahiMD : A large observat study showed no difference in risk of major CV events in RA pts that were newly started on either MTX or HCQ. A greater stroke risk but lower risk of MI; hospitalized HF was seen in MTX initiators. #Abst1993 #ACR20
Dr. John Cush RheumNow ( View Tweet)
Check out the latest from Dr. Bella Mehta ( @bella_mehta) #ACR20
Racial disparities in Bilateral Knee Arthroplasty in Osteoarthritis
https://t.co/yataL7H8X4 https://t.co/xT1vCBDLyZ
Links:
Dr. John Cush RheumNow ( View Tweet)
Revisit #ACR20 through the RheumNow podcast. Day 2, Part II available now.
https://t.co/NipWyiTqtl https://t.co/kBz2jVaSLN
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
"RT @drdavidliew : Just a reminder:
inflammatory arthritis irAEs can occur at almost any time after immune checkpoint inhibitor cancer immunotherapy is commenced.
@LoyolaChicago #ACR20 ABST1566 @RheumNow https://t.co/x7DLzZcn9o https://t.co/OmpTAorA13
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Ruderman ( @JointMD) discusses a new pathway - the use of deucravacitinib - to treat psoriatic arthritis at #ACR20.
https://t.co/1uz47jKVPv https://t.co/1I5B14w9Ox
Links:
Dr. John Cush RheumNow ( View Tweet)
Imaging and Large Vessel Vasculitis: Dr. Alexa S. Meara interviews Dr. Kaitlin Quinn #ACR20
https://t.co/CWN2C1P6Fz https://t.co/yHg63VPkiW
Links:
Dr. John Cush RheumNow ( View Tweet)
Pregnancy in SpA Patients: Dr Rachel Tate ( @uptoTate) #ACR20
https://t.co/GPrwd9HU5W https://t.co/TbwN4dZNul
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @MeralElRamahiMD : Wonder if you can predict which pts you can taper off bDMARDs? Abst#1538 from Denmark showed that a neg IgM-RF (OR 0.26); low Doppler serum score for 24 jts predicted discontinuation of bDMARDs at 2yr f/u in RA pts w/ DAS28-CRP<2.6. https://t.co/6hv5M1CQwT
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @bella_mehta :Anakinra in #Stills disease - Dbl blind, placebo controlled RCT in Stills disease total 12pts, 6 placebo, 6 Rx grp. All pts reached ACR70 at wk 2 without fever and sustained it at 12 weeks. 5/6 reached ACR90
ABS#1633 https://t.co/CCL6GONnvX https://t.co/KaoXBj3Azp
Links:
Dr. John Cush RheumNow ( View Tweet)
Coal Miners and RA: Dr Janet Pope ( @Janetbirdope) reviews abstract #1462 presented at #ACR20.
https://t.co/frZ3uYNsuA https://t.co/nFHmzYA8KS
Links:
Dr. John Cush RheumNow ( View Tweet)
Revist #ACR20. The RheumNow podcast on Day 2, Part I is available for download.
https://t.co/VAPnzYtCIK https://t.co/Pm9g8S1jmn
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @RichardPAConway : Dr Benard reports an SLR and meta-analysis of 27 studies comparing 2 rituximab regimes in AAV. 375mg x4 and 1000mg x2 equivalent. Remission in 91% vs 85%. Similar adverse event rates @rheumnow #ACR20 Abstr#2048 https://t.co/6fQNzqsvby
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @doctorRBC : Rheumatology reimbursement by CMS:
""If all goes well, in a few months, you will see a 16% increase in rheumatology.""
- From ACR Advocacy Updates
@RheumNow #ACR20 Abs#5M017
Dr. John Cush RheumNow ( View Tweet)
Is COVID19 infection bad for rheumatic disease patients? Dr. Jeff Curtis ( @RADoctor) reviews abstract L01 presented at #ACR20.
https://t.co/hm7geJKzNt https://t.co/gAY6k7ywLw
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @ejdein1 : Draft #ACR20 Rx Recommendations for RA: MTX monotherapy conditionally rec over csDMARD dual or triple Rx, MTX+TNFi @RheumNow https://t.co/HUucJOgQgN https://t.co/xJB2zU1y2U
Links:
Dr. John Cush RheumNow ( View Tweet)